Clinical Trials Browser

Not yet recruiting × Interventional × Efficacy × Clear all

NCT06237205 2024-02-01

Genome-Based Assessment of Niraparib (ZEJULA®) Efficacy in Advanced Solid TumorS With Homologous Recombination Deficiency

Phase 2 Not yet recruiting

Efficacy